Company Nasdaq, OTC Jerusalem, L3
Brainsway Ltd Brainsway develops Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform with FDA clearance for major depressive disorder, obsessive-compulsive disorder, and smoking addiction.
Follow Brainsway Ltd. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
4 Stories in coverage 0 Programs 11 recruiting Registered trial 6-K Nov 10 Latest SEC filing Form DOct 15 $20M sold
Timeline 4 Pipeline 0 Trials 1
Details
Headquarters Jerusalem, L3 Incorporated Israel Industry Surgical & Medical Instruments & Apparatus How the company describes itself Brainsway develops Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform with FDA clearance for major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The company is based in the United States and Israel. source